Atlas Trials

Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Clinical trial NCT05997927 · COMPLETED

Trial details

NCT number
NCT05997927
Sponsor
Jiangsu vcare pharmaceutical technology co., LTD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Moderate to Severe Atopic Dermatitis
Start date
2023-07-20
Primary completion
2024-07-09
Enrollment
149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.